EMD Serono Unclassified
FDA Approved Drugs
EMD Serono Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 27
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Social Profiles
Company Snapshot
EMD Serono Unclassified
One Technology Place, Rockland, MA 02370
U.S.A
www.emdserono.com/us-en?global_redirect=1 View on MapFDA Approved Drug Records ( 27 records )
Drug Name
GONAL-F
Product Number
1
Dosage Form
-
Strength
75 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
20378
Product Number
1
Dosage Form
-
Strength
75 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F
Product Number
2
Dosage Form
-
Strength
150 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
20378
Product Number
2
Dosage Form
-
Strength
150 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F
Product Number
3
Dosage Form
-
Strength
37.5 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
20378
Product Number
3
Dosage Form
-
Strength
37.5 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F
Product Number
4
Dosage Form
-
Strength
1,050 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
20378
Product Number
4
Dosage Form
-
Strength
1,050 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F
Product Number
5
Dosage Form
-
Strength
450 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
20378
Product Number
5
Dosage Form
-
Strength
450 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F
Product Number
1
Dosage Form
-
Strength
37.5 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21765
Product Number
1
Dosage Form
-
Strength
37.5 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F
Product Number
3
Dosage Form
-
Strength
150 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21765
Product Number
3
Dosage Form
-
Strength
150 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F RFF
Product Number
2
Dosage Form
-
Strength
75 IU/VIAL
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21765
Product Number
2
Dosage Form
-
Strength
75 IU/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F RFF REDI-JECT
Product Number
1
Dosage Form
-
Strength
300 IU/0.5ML
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21684
Product Number
1
Dosage Form
-
Strength
300 IU/0.5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F RFF REDI-JECT
Product Number
2
Dosage Form
-
Strength
450 IU/0.75ML
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21684
Product Number
2
Dosage Form
-
Strength
450 IU/0.75ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F RFF REDI-JECT
Product Number
3
Dosage Form
-
Strength
900 IU/1.5ML
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21684
Product Number
3
Dosage Form
-
Strength
900 IU/1.5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
GONAL-F RFF REDI-JECT
Product Number
4
Dosage Form
-
Strength
150 IU/0.25ML
Approval Date
-
Active Ingredient
FOLLITROPIN ALFA/BETA
Application Number
21684
Product Number
4
Dosage Form
-
Strength
150 IU/0.25ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
OVIDREL
Product Number
1
Dosage Form
-
Strength
0.25MG/VIAL
Approval Date
-
Active Ingredient
CHORIOGONADOTROPIN ALFA
Application Number
21149
Product Number
1
Dosage Form
-
Strength
0.25MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
OVIDREL
Product Number
2
Dosage Form
-
Strength
EQ 0.25MG /0.5ML
Approval Date
-
Active Ingredient
CHORIOGONADOTROPIN ALFA
Application Number
21149
Product Number
2
Dosage Form
-
Strength
EQ 0.25MG /0.5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SAIZEN
Product Number
1
Dosage Form
-
Strength
6MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
19764
Product Number
1
Dosage Form
-
Strength
6MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SAIZEN
Product Number
2
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
19764
Product Number
2
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SAIZEN
Product Number
3
Dosage Form
-
Strength
8.8MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
19764
Product Number
3
Dosage Form
-
Strength
8.8MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SAIZEN
Product Number
5
Dosage Form
-
Strength
4MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
19764
Product Number
5
Dosage Form
-
Strength
4MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SEROSTIM
Product Number
1
Dosage Form
-
Strength
6MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20604
Product Number
1
Dosage Form
-
Strength
6MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SEROSTIM
Product Number
2
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20604
Product Number
2
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SEROSTIM
Product Number
3
Dosage Form
-
Strength
4MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20604
Product Number
3
Dosage Form
-
Strength
4MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SEROSTIM
Product Number
4
Dosage Form
-
Strength
8.8MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20604
Product Number
4
Dosage Form
-
Strength
8.8MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SEROSTIM LQ
Product Number
5
Dosage Form
-
Strength
6MG/0.5ML (6MG/0.5ML)
Approval Date
-
Active Ingredient
SOMATROPIN
Application Number
20604
Product Number
5
Dosage Form
-
Strength
6MG/0.5ML (6MG/0.5ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZORBTIVE
Product Number
1
Dosage Form
-
Strength
4MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN RECOMBINANT
Application Number
21597
Product Number
1
Dosage Form
-
Strength
4MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZORBTIVE
Product Number
2
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN RECOMBINANT
Application Number
21597
Product Number
2
Dosage Form
-
Strength
5MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZORBTIVE
Product Number
3
Dosage Form
-
Strength
6MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN RECOMBINANT
Application Number
21597
Product Number
3
Dosage Form
-
Strength
6MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZORBTIVE
Product Number
4
Dosage Form
-
Strength
8.8MG/VIAL
Approval Date
-
Active Ingredient
SOMATROPIN RECOMBINANT
Application Number
21597
Product Number
4
Dosage Form
-
Strength
8.8MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
32 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
27 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
GONAL-F
Application Number
20378
Product Number
1
Active Ingredient
FOLLITROPIN ALFA/BETA
Dosage Form
-
Strength
75 IU/VIAL
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.